These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26380421)

  • 1. THROMBOCYTOPENIA WITH GABAPENTIN USAGE.
    Atakli D; Yuksel B; Ak PD; Sariahmetoglu H; Sari H
    Ideggyogy Sz; 2015 Jul; 68(7-8):270-2. PubMed ID: 26380421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and tolerability of dose-escalation with generic gabapentin--a multicenter, non-interventional study].
    Rejdak K; Lipa A; Kaczyński K; Stelmasiak Z;
    Wiad Lek; 2011; 64(2):91-6. PubMed ID: 22026272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abuse potential of gabapentin in dentistry.
    Weinberg MA; Segelnick SL; Insler JS
    Gen Dent; 2017; 65(6):73-75. PubMed ID: 29099371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregabalin: new drug. Very similar to gabapentin.
    Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A novel antiepileptic, gabapentin (GABAPEN)].
    Kunihara M; Sase S; Arakawa A
    Nihon Yakurigaku Zasshi; 2007 Apr; 129(4):299-307. PubMed ID: 17435343
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic drug monitoring of gabapentin].
    Tribut O; Bentué-Ferrer D; Verdier MC;
    Therapie; 2010; 65(1):57-60. PubMed ID: 20205997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral ballism induced by gabapentin in idiopatic Parkinson's disease.
    Erol C; Ozben S; Ozer F; Cetin S; Tiras R
    Clin Neurol Neurosurg; 2009 May; 111(4):397. PubMed ID: 19118940
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study.
    Yamauchi T; Kaneko S; Yagi K; Sase S
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):507-15. PubMed ID: 16884455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive pregabalin vs gabapentin for focal seizures: Interpretation of comparative outcomes.
    French J; Glue P; Friedman D; Almas M; Yardi N; Knapp L; Pitman V; Posner HB
    Neurology; 2016 Sep; 87(12):1242-9. PubMed ID: 27521437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure.
    Pierce DA; Holt SR; Reeves-Daniel A
    Clin Ther; 2008 Sep; 30(9):1681-4. PubMed ID: 18840374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group.
    Baulac M; Cavalcanti D; Semah F; Arzimanoglou A; Portal JJ
    Seizure; 1998 Feb; 7(1):55-62. PubMed ID: 9548227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analgesic effect of gabapentin as a prophylactic anticonvulsant drug on postcraniotomy pain: a prospective randomized study.
    Türe H; Sayin M; Karlikaya G; Bingol CA; Aykac B; Türe U
    Anesth Analg; 2009 Nov; 109(5):1625-31. PubMed ID: 19713257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol.
    Bonnet U; Hamzavi-Abedi R; Specka M; Wiltfang J; Lieb B; Scherbaum N
    Alcohol Alcohol; 2010; 45(2):143-5. PubMed ID: 20019070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group.
    Morrell MJ; McLean MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus L; Bernstein P; Rose-Legatt
    Seizure; 2000 Jun; 9(4):241-8. PubMed ID: 10880282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gabapentin-induced central hypoventilation].
    Català Pérez R; Gámez Lechuga M; Martínez-Lage Alvarez M; Antón Albisu A
    Med Clin (Barc); 2007 Apr; 128(13):519. PubMed ID: 17419921
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical efficacy and safety of gabapentin.
    Ramsay RE
    Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal symptoms after gabapentin discontinuation.
    Hellwig TR; Hammerquist R; Termaat J
    Am J Health Syst Pharm; 2010 Jun; 67(11):910-2. PubMed ID: 20484214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel long-term anticonvulsant treatment with gabapentin without causing memory impairment in mice.
    Blake MG; Boccia MM; Carcaboso AM; Chiappetta DA; Höcht C; Krawczyk MC; Sosnik A; Baratti CM
    Epilepsy Behav; 2010 Feb; 17(2):157-64. PubMed ID: 20079694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delirium after gabapentin withdrawal. Case report.
    Di Fabio R; D'Agostino C; Baldi G; Pierelli F
    Can J Neurol Sci; 2013 Jan; 40(1):126-7. PubMed ID: 23427359
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of gabapentin therapy in children with refractory partial seizures.
    Khurana DS; Riviello J; Helmers S; Holmes G; Anderson J; Mikati MA
    J Pediatr; 1996 Jun; 128(6):829-33. PubMed ID: 8648543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.